• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: EPILEPSY

Adjunctive therapy in focal epilepsy – highlights from AES 2025

December 23, 2025  

Management of refractory epilepsy: highlights from ILAE 2025

October 29, 2025  

Epilepsy Management 2025: Use of Adjunctive Therapies in Practice

May 22, 2025  

Adjunctive cenobamate for focal epilepsy – data review and use in clinical practice

February 11, 2025  

New advances in epilepsy: highlights from AES 2024

December 17, 2024  

Cenobamate as adjunctive therapy for partial-onset seizures: a review

October 25, 2024  

ECTRIMS 2024 HIGHLIGHTS – FRIDAY, SEPTEMBER 20, 2024

September 20, 2024  

Meta-analysis of CBD meta-analyses reports efficacy in younger patients with seizure disorders

August 26, 2024  

What is the seizure risk after stopping antiseizure medications?

August 5, 2024  

REPORT FROM EAN 2024 – WEDNESDAY, JULY 3, 2024

July 3, 2024  
1
2
3
4

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Revised recommendations on the differential diagnosis of MS posted on July 25, 2023
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions